ImmunityBio, Inc. Class Action Lawsuit – IBRX
Company: ImmunityBio, Inc.
Ticker: (NASDAQ) IBRX
Deadline
Passed
Lead Plaintiff Deadline: May 26, 2026
Never Miss Another Deadline
Choose your preferred way to stay informed of new case launches and settlement deadlines.
Get Updates by Email
Subscribe for email notifications.
Allegations
The filed complaint alleges that ImmunityBio, Inc. made materially false and/or misleading statements and/or failed to disclose that:
(1) defendant Soon-Shion materially overstated Anktiva’s capabilities; and (2) as a result, defendants’ statements about ImmunityBio’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.